This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit April 02, 2014


 

Advertisement

Younger men benefit most from surgery for localized prostate cancer
Oncology Nurse Advisor
A new study found substantial long-term reduction in mortality for men with localized prostate cancer who undergo a radical prostatectomy. Although the benefit on mortality appears to be limited to men younger than 65 years, surgery did reduce the risk of metastases and need for additional treatment in older men. More than 230,000 men will be diagnosed with prostate cancer this year in the United States, but determining their course of treatment remains a source of considerable debate.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  


Advertisement
SPONSORED CONTENT


Obesity primes the colon for cancer, according to NIH study
National Institutes of Health
Obesity, rather than diet, causes changes in the colon that may lead to colorectal cancer, according to a study in mice by the National Institutes of Health. The finding bolsters the recommendation that calorie control and frequent exercise are not only key to a healthy lifestyle, but a strategy to lower the risk for colon cancer, the second leading cause of cancer-related death in the United States.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Version 3 of the CP³R now available
ACS
The latest version of the Cancer Program Practice Profile Reports (CP³R) has been posted with the following features:
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  The Top 10 Metrics to Maximize Your Practice's Revenue

MediGain has analyzed the top physicians offices around the country and compiled the Top 10 Metrics they use to maximize their practice's revenue. You can't manage what you can't measure. Here are 10 metrics that you can track so you can spend more time providing quality health care for your patients. Plus, you will end up with more cash at the end of the day/month/year.
 


FDA panel backs non-invasive colon cancer screening alternative
CBS News
A panel of Food and Drug Administration (FDA) advisers has voted to endorse an experimental stool test that uses DNA to detect colon cancer and precancerous growths. The FDA's committee of genetic experts voted 10-0 that the benefits of Exact Sciences' Cologuard test outweigh its risks. The vote amounts to a recommendation for the FDA to approve the test from Exact Sciences of Madison, Wis. The agency is not required to follow the panel's advice, but often does.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Register now for the 2014 CoC workshop — Strengthening Your Cancer Program...Enriching the Coordinators' Role
Commission on Cancer
On June 19-20 in Chicago, the Commission on Cancer (CoC) will hold a new workshop entitled Strengthening Your Cancer Program…Enriching the Coordinators' Role. This program provides information and case studies on the roles and responsibilities of the various CoC-designated coordinators. The two-day program will cover what the various coordinators' roles are, what their roles on the cancer committee involve, and how to meet and improve the required responsibilities based on the CoC Standards. Register for the program. Program fees are $650 if registration is received on or before May 15 and $750 if registration is received after May 15.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Could half of all breast cancers be prevented?
Reuters
If girls and women of all ages adopted healthier lifestyle behaviors and the highest-risk women took preventive drugs like tamoxifen, the authors of a new report say fully half of breast cancers in the U.S. might be avoided. "We really need to go back and work at breast cancer prevention starting at a young age," Dr. Graham Colditz, associate director for prevention and control at Siteman Cancer Center and Washington University in St. Louis, a co-author of the report, told Reuters Health.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Palliative chemotherapy may overshadow patients' wishes for end-of-life care
Oncology Nurse Advisor
Terminal cancer patients who receive chemotherapy in the last months of their lives are less likely to die where they want and are more likely to undergo invasive medical procedures than those who do not receive chemotherapy, according to newly published research. The findings, published in BMJ, underscore a disconnect between the type of care many cancer patients say they want and the kind they receive, and highlight the need for clearer and more balanced discussion of the harms and benefits of palliative chemotherapy at the end of life between doctors, patients, and families, the study authors said.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Register now — Strengthening Your Cancer Program... Utilizing the Rapid Quality Reporting System to Comply with the New Commendation Standard
Commission on Cancer
Strengthening Your Cancer Program...Utilizing the Rapid Quality Reporting System to Comply with the New Commendation Standard will be held on June 18 in Chicago, the day before the 2014 CoC Workshop. This workshop will provide important information to help your program comply with the new commendation standard that requires programs, from initial enrollment and throughout the three-year accreditation period, to participate in the Rapid Quality Reporting System (RQRS). Register now for the program; registration fees are $250 if registration is received on or before May 15 and $300 if registration is received after May 15, 2014.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Urine test could help predict recurrence of bladder cancer
Medical News Today
Individuals who have had bladder cancer in the past are at high risk of recurrence, but researchers publishing in the journal Clinical Cancer Research say a simple DNA methylation marker test in urine can predict tumor recurrence. The researchers were led by Gangning Liang, PhD, an associate professor in the department of urology at the University of Southern California Norris Comprehensive Cancer Center in Los Angeles.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Invasive cancer incidence — United States, 2010
CDC
Cancer has many causes, some of which can, at least in part, be avoided through interventions known to reduce cancer risk. Healthy People 2020 objectives call for reducing colorectal cancer incidence to 38.6 per 100,000 persons, reducing late-stage breast cancer incidence to 41.0 per 100,000 women, and reducing cervical cancer incidence to 7.1 per 100,000 women. To assess progress toward reaching these Healthy People 2020 targets, CDC analyzed data from U.S. Cancer Statistics (USCS) for 2010. USCS includes incidence data from CDC's National Program of Cancer Registries and the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program and mortality data from the National Vital Statistics System.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


The Recovery Room Show — New episode available
ACS
You understand health, but do you understand medicine? Making sense of modern medicine, The Recovery Room, supported by the American College of Surgeons and hosted by Frederick L. Greene, MD, FACS, is an audio conversation with experts in surgery, medicine, ethics, and public health about the latest developments in medicine and health care. The latest episode, "Smoking Cessation and the Surgical Patient," is now available. It features Eric Skipper, MD, FACS, chief of adult cardiothoracic surgery at the Sanger Heart & Vascular Institute, Charlotte, N.C., and Michael Rosen, MD, FACS, professor of surgery and chief of GI and general surgery at Case Western Reserve University, Cleveland, Ohio.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Cancer screening promotion via interactive phone messages
HealthDay News via Monthly Prescribing Reference
Underserved Latina patients view interactive voice response (IVR) messages as an acceptable strategy to promote cancer screening, according to a study published online March 13 in the US Centers for Disease Control and Prevention's Preventing Chronic Disease. Mary L. Greaney, PhD, from the University of Rhode Island in Kingston, and colleagues conducted seven focus groups with 40 Latina community health center patients in need of one or more cancer screenings.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Excellent outcomes with proton therapy in prostate cancer
Medscape (login required)
Proton-beam therapy is a controversial alternative to conventional radiotherapy for prostate cancer patients; opponents say that evidence supporting its use just isn't there. However, a new study shows "extremely high efficacy" in five-year outcomes for patients in all risk categories treated with proton-beam therapy. The five-year rates of freedom from biochemical and/or clinical progression were 99 percent in low-risk patients, 99 percent in intermediate-risk patients, and 76 percent in high-risk patients.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


National Accreditation Program for Breast Centers presents the Pursuing Excellence through Accreditation Workshop
NAPBC
Plan now to attend the Pursuing Excellence through Accreditation Workshop May 23 in Chicago. Designed for centers seeking accreditation for the first time as well as centers due for re-accreditation, this program will increase your understanding of the National Accreditation Program for Breast Centers (NAPBC) accreditation process and help you prepare for the survey visit. Space is limited, so please make sure you register early.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 
Advertisement

Advertisement



The CoC Brief

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Samantha Emerson, Content Editor, 469.420.2669
Contribute news

Disclaimer: The CoC Brief is a digest of the most important news selected for the American College of Surgeons Commission on Cancer from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Commission on Cancer does not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of the American College of Surgeons and the Commission on Cancer.


Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of The CoC Brief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues

March 26, 2014
March 19, 2014
March 19, 2014
March 12, 2014






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063